Timea Babos / Luisa Stefani vs Alicia Barnett / Elixane Lechemia
Summary
Match Info
Analysis
Summary: The market price overstates the home pairing's odds based on the supplied profiles; at 1.325 there is no value. We recommend no bet.
Highlights
- • Market-implied home probability ~75.5%
- • Our conservative true probability estimate for the home side is ~58%, producing negative EV at current prices
Pros
- + Home team is priced as a clear favorite in the market
- + If additional inside info (injury to opponent or strong partnership history) emerges, price could be justified
Cons
- - Provided player records and recent results do not support a >75% win probability
- - Current odds are too short to produce positive expected value with our estimate
Details
We compare the market price (home 1.325 -> implied 75.5%) against our assessment of the true chance. The public price implies a very strong favorite, but the supplied player profiles do not show a clear performance advantage for the home pairing. Babos and Stefani's recent compiled records in the research are mixed and neither profile shows dominant recent form; Alicia Barnett has a long, positive career doubles record which offsets Stefani/Lechemia inconsistencies. There is no surface or recent form data in the research that strongly supports a >75% win probability for the home duo, so the market is likely overpricing them. Using a conservative estimated true probability of 58% for the home team yields a negative expected value at the current decimal price (1.325), so we do not recommend backing the home favorite at these odds.
Key factors
- • Market implies 75.5% for home; supplied player data does not justify such a high edge
- • Alicia Barnett's extensive positive career doubles record provides experience offsetting home pairing
- • Recent results for all four players in the research show mixed losses; no strong momentum for the home side